Evidence map›Paper›PMID 32066486›Full record

ArticleParasites & vectors2020

Ingested insecticide to control Aedes aegypti: developing a novel dried attractive toxic sugar bait device for intra-domiciliary control.

Rachel Sippy, Galo E Rivera, Valeria Sanchez, Froilán Heras, Bianca Morejón, Efraín Beltrán, Robert S Hikida, María A López-Latorre, Alex Aguirre, Anna M Stewart-Ibarra and 2 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Chikungunya fever.Nature reviews. Disease primers · 2023
    Review
  11. Review
  12. New tools for Aedes control: mass trapping.Current opinion in insect science · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Rachel SippyInstitute for Global Health & Translational Science, SUNY-Upstate Medical University, Syracuse, NY, USA.
Galo E RiveraCenter for Research on Health in Latin America, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Valeria SanchezInstitute for Global Health & Translational Science, SUNY-Upstate Medical University, Syracuse, NY, USA.
Froilán HerasInstitute for Global Health & Translational Science, SUNY-Upstate Medical University, Syracuse, NY, USA.
Bianca MorejónCenter for Research on Health in Latin America, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Efraín BeltránUnidad Académica de Ciencias Químicas y de la Salud, Universidad Técnica de Machala, Machala, Ecuador.
Robert S HikidaOhio University, Athens, Ohio, USA.
María A López-LatorreCenter for Research on Health in Latin America, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Alex AguirreCenter for Research on Health in Latin America, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Anna M Stewart-IbarraInstitute for Global Health & Translational Science, SUNY-Upstate Medical University, Syracuse, NY, USA. astewart@dir.iai.int.
David A LarsenDepartment of Public Health, Syracuse University, Syracuse, NY, USA. dalarsen@syr.edu.ORCID http://orcid.org/0000-0002-1876-6536
Marco NeiraCenter for Research on Health in Latin America, Pontificia Universidad Católica del Ecuador, Quito, Ecuador. mvneira@puce.edu.ec.
Pontificia Universidad Católica del Ecuador · ECSUNY Upstate Medical University · USKansas State University · USOhio University · USSyracuse University · USUniversidad Tecnica de Machala · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIllnesses transmitted by Aedes aegypti (Linnaeus, 1762) such as dengue, chikungunya and Zika comprise a considerable global burden; mosquito control is the primary public health tool to reduce disease transmission. Current interventions are inadequate and insecticide resistance threatens the effectiveness of these options. Dried attractive bait stations (DABS) are a novel mechanism to deliver insecticide to Ae. aegypti. The DABS are a high-contrast 28 inch

methodsWe conducted multiple series of laboratory and semi-field trials to assess the survivability of Ae. aegypti mosquitoes exposed to the DABS. In the laboratory experiments, we assessed the lethality, the killing mechanism, and the shelf life of the device through controlled experiments. In the semi-field trials, we released laboratory-reared female Ae. aegypti into experimental houses typical of peri-urban tropical communities in South America in three trial series with six replicates each. Laboratory experiments were conducted in Quito, Ecuador, and semi-field experiments were conducted in Machala, Ecuador, an area with abundant wild populations of Ae. aegypti and endemic arboviral transmission.

resultsIn the laboratory, complete lethality was observed after 48 hours regardless of physiological status of the mosquito. The killing mechanism was determined to be through ingestion, as the boric acid disrupted the gut of the mosquito. In experimental houses, total mosquito mortality was greater in the treatment house for all series of experiments (P < 0.0001).

conclusionsThe DABS devices were effective at killing female Ae. aegypti under a variety of laboratory and semi-field conditions. DABS are a promising intervention for interdomiciliary control of Ae. aegypti and arboviral disease prevention.

Indexed as

InsecticidesMosquito VectorsAedesAnimalsEatingEcuadorFemaleMaleMosquito ControlSugarsInsecticidesSugarsAedes aegyptiArbovirusATSBAttractive baitDengueSemi-fieldToxic sugar baitVector control

Identifiers

PMID32066486
PMCPMC7027216
OpenAlexW3008674059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.